vs

Side-by-side financial comparison of MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) and UNITED STATES LIME & MINERALS INC (USLM). Click either name above to swap in a different company.

UNITED STATES LIME & MINERALS INC is the larger business by last-quarter revenue ($87.9M vs $49.9M, roughly 1.8× MARAVAI LIFESCIENCES HOLDINGS, INC.). UNITED STATES LIME & MINERALS INC runs the higher net margin — 34.7% vs -71.6%, a 106.3% gap on every dollar of revenue. On growth, UNITED STATES LIME & MINERALS INC posted the faster year-over-year revenue change (9.8% vs -11.8%). UNITED STATES LIME & MINERALS INC produced more free cash flow last quarter ($25.7M vs $-24.9M). Over the past eight quarters, UNITED STATES LIME & MINERALS INC's revenue compounded faster (10.8% CAGR vs -11.9%).

Maravai LifeSciences Holdings is a global life sciences firm developing critical reagents, diagnostic products, and tech solutions to support biopharma research, drug development, clinical diagnostics, and cell/gene therapy manufacturing. It serves biotech, pharma, research bodies and labs worldwide across three core segments.

United States Lime & Minerals Inc is a leading US-based natural resources enterprise that produces high-calcium lime, dolomitic lime, limestone and related mineral products. Its core client segments cover infrastructure construction, steel manufacturing, agricultural soil amendment, environmental emission control and industrial processing, serving customers across North America.

MRVI vs USLM — Head-to-Head

Bigger by revenue
USLM
USLM
1.8× larger
USLM
$87.9M
$49.9M
MRVI
Growing faster (revenue YoY)
USLM
USLM
+21.7% gap
USLM
9.8%
-11.8%
MRVI
Higher net margin
USLM
USLM
106.3% more per $
USLM
34.7%
-71.6%
MRVI
More free cash flow
USLM
USLM
$50.5M more FCF
USLM
$25.7M
$-24.9M
MRVI
Faster 2-yr revenue CAGR
USLM
USLM
Annualised
USLM
10.8%
-11.9%
MRVI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MRVI
MRVI
USLM
USLM
Revenue
$49.9M
$87.9M
Net Profit
$-35.7M
$30.5M
Gross Margin
25.8%
48.0%
Operating Margin
-117.9%
41.0%
Net Margin
-71.6%
34.7%
Revenue YoY
-11.8%
9.8%
Net Profit YoY
-37.7%
13.2%
EPS (diluted)
$-0.24
$1.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MRVI
MRVI
USLM
USLM
Q4 25
$49.9M
$87.9M
Q3 25
$41.6M
$102.0M
Q2 25
$47.4M
$91.5M
Q1 25
$46.9M
$91.3M
Q4 24
$56.6M
$80.1M
Q3 24
$69.0M
$89.4M
Q2 24
$69.4M
$76.5M
Q1 24
$64.2M
$71.7M
Net Profit
MRVI
MRVI
USLM
USLM
Q4 25
$-35.7M
$30.5M
Q3 25
$-25.6M
$38.8M
Q2 25
$-39.6M
$30.8M
Q1 25
$-29.9M
$34.1M
Q4 24
$-25.9M
$27.0M
Q3 24
$-97.1M
$33.4M
Q2 24
$-9.8M
$26.1M
Q1 24
$-12.1M
$22.4M
Gross Margin
MRVI
MRVI
USLM
USLM
Q4 25
25.8%
48.0%
Q3 25
13.6%
51.2%
Q2 25
16.4%
45.8%
Q1 25
16.5%
50.6%
Q4 24
34.3%
44.3%
Q3 24
46.7%
48.2%
Q2 24
44.4%
45.5%
Q1 24
40.3%
42.7%
Operating Margin
MRVI
MRVI
USLM
USLM
Q4 25
-117.9%
41.0%
Q3 25
-98.6%
45.3%
Q2 25
-139.8%
39.0%
Q1 25
-104.9%
43.7%
Q4 24
-66.7%
38.8%
Q3 24
-239.9%
42.6%
Q2 24
-19.4%
39.1%
Q1 24
-29.4%
35.9%
Net Margin
MRVI
MRVI
USLM
USLM
Q4 25
-71.6%
34.7%
Q3 25
-61.4%
38.0%
Q2 25
-83.5%
33.7%
Q1 25
-63.9%
37.4%
Q4 24
-45.8%
33.7%
Q3 24
-140.6%
37.3%
Q2 24
-14.1%
34.0%
Q1 24
-18.8%
31.3%
EPS (diluted)
MRVI
MRVI
USLM
USLM
Q4 25
$-0.24
$1.06
Q3 25
$-0.18
$1.35
Q2 25
$-0.27
$1.07
Q1 25
$-0.21
$1.19
Q4 24
$-0.21
$-2.20
Q3 24
$-0.68
$1.16
Q2 24
$-0.07
$0.91
Q1 24
$-0.09
$3.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MRVI
MRVI
USLM
USLM
Cash + ST InvestmentsLiquidity on hand
$216.9M
$371.1M
Total DebtLower is stronger
$291.8M
$0
Stockholders' EquityBook value
$212.4M
$630.8M
Total Assets
$770.6M
$681.0M
Debt / EquityLower = less leverage
1.37×
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MRVI
MRVI
USLM
USLM
Q4 25
$216.9M
$371.1M
Q3 25
$243.6M
$349.5M
Q2 25
$269.9M
$319.9M
Q1 25
$285.1M
$300.6M
Q4 24
$322.4M
$278.0M
Q3 24
$578.2M
$255.0M
Q2 24
$573.2M
$222.5M
Q1 24
$561.7M
$207.0M
Total Debt
MRVI
MRVI
USLM
USLM
Q4 25
$291.8M
$0
Q3 25
$292.8M
$0
Q2 25
$293.9M
$0
Q1 25
$294.9M
$0
Q4 24
$295.9M
$0
Q3 24
$521.7M
$0
Q2 24
$522.5M
$0
Q1 24
$523.3M
$0
Stockholders' Equity
MRVI
MRVI
USLM
USLM
Q4 25
$212.4M
$630.8M
Q3 25
$245.4M
$602.3M
Q2 25
$265.9M
$563.3M
Q1 25
$300.6M
$532.2M
Q4 24
$325.3M
$497.7M
Q3 24
$344.9M
$474.2M
Q2 24
$434.7M
$441.1M
Q1 24
$410.7M
$415.3M
Total Assets
MRVI
MRVI
USLM
USLM
Q4 25
$770.6M
$681.0M
Q3 25
$849.2M
$652.8M
Q2 25
$897.0M
$607.4M
Q1 25
$959.8M
$585.3M
Q4 24
$1.0B
$543.2M
Q3 24
$1.3B
$521.8M
Q2 24
$1.4B
$484.2M
Q1 24
$1.4B
$464.0M
Debt / Equity
MRVI
MRVI
USLM
USLM
Q4 25
1.37×
0.00×
Q3 25
1.19×
0.00×
Q2 25
1.11×
0.00×
Q1 25
0.98×
0.00×
Q4 24
0.91×
0.00×
Q3 24
1.51×
0.00×
Q2 24
1.20×
0.00×
Q1 24
1.27×
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MRVI
MRVI
USLM
USLM
Operating Cash FlowLast quarter
$-22.8M
$45.6M
Free Cash FlowOCF − Capex
$-24.9M
$25.7M
FCF MarginFCF / Revenue
-49.9%
29.2%
Capex IntensityCapex / Revenue
4.2%
22.6%
Cash ConversionOCF / Net Profit
1.49×
TTM Free Cash FlowTrailing 4 quarters
$-70.7M
$102.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MRVI
MRVI
USLM
USLM
Q4 25
$-22.8M
$45.6M
Q3 25
$-15.2M
$45.9M
Q2 25
$-10.3M
$34.0M
Q1 25
$-9.4M
$39.4M
Q4 24
$-14.6M
$38.6M
Q3 24
$13.1M
$39.0M
Q2 24
$17.4M
$21.2M
Q1 24
$-8.5M
$27.2M
Free Cash Flow
MRVI
MRVI
USLM
USLM
Q4 25
$-24.9M
$25.7M
Q3 25
$-18.1M
$31.3M
Q2 25
$-13.1M
$20.8M
Q1 25
$-14.6M
$24.6M
Q4 24
$-20.5M
$27.6M
Q3 24
$4.5M
$33.9M
Q2 24
$7.9M
$16.8M
Q1 24
$-14.1M
$20.3M
FCF Margin
MRVI
MRVI
USLM
USLM
Q4 25
-49.9%
29.2%
Q3 25
-43.4%
30.7%
Q2 25
-27.7%
22.7%
Q1 25
-31.2%
26.9%
Q4 24
-36.2%
34.4%
Q3 24
6.6%
37.9%
Q2 24
11.4%
21.9%
Q1 24
-22.0%
28.4%
Capex Intensity
MRVI
MRVI
USLM
USLM
Q4 25
4.2%
22.6%
Q3 25
7.0%
14.4%
Q2 25
6.1%
14.5%
Q1 25
11.2%
16.3%
Q4 24
10.3%
13.8%
Q3 24
12.4%
5.8%
Q2 24
13.8%
5.7%
Q1 24
8.8%
9.5%
Cash Conversion
MRVI
MRVI
USLM
USLM
Q4 25
1.49×
Q3 25
1.18×
Q2 25
1.10×
Q1 25
1.16×
Q4 24
1.43×
Q3 24
1.17×
Q2 24
0.81×
Q1 24
1.21×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MRVI
MRVI

Cygnus Segment$27.2M54%
Other$18.4M37%
Shipping And Handling$4.3M9%

USLM
USLM

Segment breakdown not available.

Related Comparisons